Text message pilot boosts antimalarial uptake among pregnant women in Uganda

A pregnant woman receives her IPTp drugs from a health worker in West Nile, Uganda

A pregnant woman receives her IPTp drugs from a health worker in West Nile, Uganda


Daily text messages reminding health workers to encourage pregnant women to take their antimalarial drugs are helping to significantly improve uptake of the treatment in Uganda.
The text message pilot is part of a wider project being led by COMDIS-HSD partners, Malaria Consortium. The project aims to identify and address the factors that prevent women from receiving and taking the proper preventive malaria treatments during pregnancy.
Malaria in pregnancy poses substantial risks to mother and unborn child, including maternal anaemia, stillbirth, miscarriage and low birth weight – a leading cause of child mortality. The World Health Organization (WHO) recommends intermittent preventative treatment in pregnancy (IPTp). This is a full therapeutic course of antimalarial medicine given to pregnant women living in areas of moderate or high transmission, regardless of whether or not they are infected with malaria, to prevent malaria infections.
However, our research in Uganda has found mixed knowledge among health workers regarding IPTp guidelines, as well as the fact they do not always offer IPTp or encourage women to take it.
Designed to complement the standard training on malaria in pregnancy, the text message intervention involves sending daily reminders to health workers for five weeks, summarising the key points of the training.

  • 6 months after the training, health workers who received training plus text messages had a better recollection of IPTp guidelines than health workers who had received only training.
  • In health facilities where health workers received the text messages, the coverage among women of the third and fourth IPTp doses was almost double that in health facilities where the text message system was not implemented.

Based on these promising results, the Ministry of Health in Uganda, which has been involved in the design and implementation of the study, has decided that instructions on sending text message reminders should be added to the national malaria in pregnancy training guidelines.

World TB Day 2016: What we’re doing at COMDIS-HSD to End TB

One of our series of Tweets to showcase our TB work on World TB Day 2016

One of our series of Tweets to showcase our TB work on World TB Day 2016


This year the World Health Organization (WHO) is calling on countries to ‘Unite to End TB’. Ending TB by 2030 is a target of the Sustainable Development Goals and a programme priority for COMDIS-HSD and our partners.
More than 4,000 people lose their lives each day to this leading infectious disease. Many of the communities that are most burdened by tuberculosis are poor, vulnerable and marginalised.
WHO has highlighted some important progress in the 30 countries with the highest TB burden. It says that a number of countries are strengthening the strategic agendas of their TB programmes by adopting newer tools, extending access to care and linking with other parts of government to reduce the financial costs for patients.
At COMDIS-HSD we are contributing in all these areas and on World TB Day 2016 we’re taking the opportunity to share more widely some of our research and key findings:
Video briefings

Blog

Research evidence

A patient featured in HERD's special series on TB: "I have not only been helped economically but psychologically too."

A patient featured in HERD’s special series on TB: “I have not only been helped economically but psychologically too.”


In addition to their ongoing TB research, our partners are also taking active parts in this year’s World TB Day activities. HERD Nepal is taking the TB message out to the community by sharing material and talking about the stigma related to TB. See their full report of the day’s activities in Nepal.
HERD have also produced a special series of articles and insights celebrating Nepal’s efforts towards tuberculosis control, particularly over the last 10 years.
The series includes some interesting personal perspectives from policy makers, medical practitioners and patients about how they view TB interventions and services.
One patient featured in the series was diagnosed with MDR-TB but was concerned that she could not afford the lengthy 20-month treatment. However, doctors referred her to a facility where she is receiving free MDR-TB treatment and hostel accommodation.
“I have not only been helped economically but psychologically too. When I first came here, I was not sure what was going to happen but with the constant support from the staff and other patients, I realised I was in safe hands. Now I am confident I will stay here and receive the treatment and return home fully recovered from the disease.”
In Bangladesh, ARK Foundation joined up with their partners at the National TB Control Programme, marching with banners in the lively World TB Day rally in Dhaka.
The ARK team take to the streets of Dhaka with their End TB message on World TB Day 2016

The ARK team take to the streets of Dhaka with their End TB message on World TB Day 2016


The day’s activities were covered by a number of electronic and print media. Dr Md Quamrul Islam, Director of Mycobacterium Disease Control (MBDC) and Line Director of TB and Leprosy thanked all partner NGOs for their active participation in observing World TB Day 2016.
 

Dr Rumana Huque talks about the challenges of providing free TB treatment for factory workers

A Directly Observed Treatment corner in a garment factory in Bangladesh

A Directly Observed Treatment corner in a garment factory in Bangladesh


On 24th March, it will be World TB Day. Under the National TB Programme (NTP), we can all make use of free TB diagnosis and treatment. But uptake to this free service is surprisingly slow. Why is this?
My personal view is that there are still many myths that we have to overcome, the biggest one being that TB cannot be cured. This is simply not true: TB is 100% curable, and each and every one of us can have free treatment if we go to any of the NTP clinics for diagnosis and treatment.
If you work in a factory that is part of the Bangladesh Garment Manufacturers and Exporters Association (BGMEA), then their doctor or paramedic can test you for free, without you losing your pay or having to stop work for treatment. However, not all factories are part of BGMEA, and we at ARK Foundation know the challenges of trying to persuade employers to invest in diagnosis and treatment for their staff.
When we conducted research, with the help of the BGMEA factories, we found that factory managers were reluctant to allow workers to visit TB diagnosis centres during working hours, and also reluctant to allow their staff to continue working once they were diagnosed with TB. In some factories, even the workers were uncomfortable accepting their colleagues back into the workplace.
We also found that some medical staff based in the factories thought that keeping up-to-date treatment records was time-consuming, and factories without medical facilities struggled to organise the referral mechanism that we were proposing, and struggled to maintain records.
All these challenges still exist, and do not help the cause of fighting TB. What did we do to tackle these challenges? We held orientation and educational activities for a large number of workers to challenge the stigma and myths surrounding TB. Most importantly, we gave them information on how they can get free diagnosis and treatment, and we persuaded factory managers that it was in their best interests (and ultimately more profitable) if they didn’t sack workers who were diagnosed with TB, but instead let them continue treatment while working for them.
Our project had a 100% success rate; everyone who worked in the BGMEA factories who was diagnosed with TB went on to complete their treatment and is 100% cured.
So what can we take away from this? My view is that providing workplace TB control depends on the management’s good understanding of what it takes to control TB in the workplace. Management also need to commit to allowing workers diagnosed with TB to continue to work in their factories and visit diagnosis centres during working hours.
Our experience of working with BGMEA factories can easily be replicated in other business sectors. However, national policies and funds should be mobilised to provide encouragement and support. Armed with this evidence, the NTP is in a strong position to initiate relationships with trade associations to help the workers and managers of Bangladesh control TB.
Dr Rumana Huque is Executive Director of ARK Foundation in Bangladesh.

Small, focused, well designed qualitative studies are critically important to our learning

Dr Rebecca King, Researcher, COMDIS-HSD

Dr Rebecca King, Researcher, COMDIS-HSD


The recent Open Letter to the BMJ editors highlighted a concern held by many qualitative researchers. At COMDIS-HSD, we welcome the open letter to the BMJ editors and agree that there are a number of leading journals that give low priority to qualitative research
COMDIS-HSD considers the contribution of qualitative research to intervention development and evaluation to be critical. Our portfolio of work includes:

  • Exploratory qualitative work to inform the development of context-appropriate interventions;
  • Qualitative methods being integrated into the piloting of interventions and research procedures, in order to assess their feasibility and acceptability; and
  • Qualitative methods used within process evaluations of complex interventions.

We are confident that our learning from qualitative research contributes to more context-appropriate, better quality, more sustainable interventions that can be implemented at scale.
However, we find that, when it comes to publication, we are constrained by a ‘quantitative paradigm’, which assesses the rigour and validity of studies based on criteria that are not always suited to qualitative research. In particular, we note bias against in-depth and focused, but sometimes quite small studies.
Our view is that small, focused, well designed and well implemented studies can be critically important to our learning, and the lessons from them can be applied widely. Such studies should not be rejected as ‘low-priority’, but rather should be considered on their own merit i.e. based on their quality and relevance. We have observed in discussion with journal editors that it can be problematic to get reviewers who fully understand both qualitative research methods and the need for pragmatism.
We advocate the publication of high quality, informative qualitative studies that draw on a wide range of methods, including interviewing, focus group discussions and observations, but also participatory approaches that give voice to participants and enable academics, policymakers and funders to continuously improve health services for those most in need.

5 take-away messages from 'Using Research Evidence: A Practical Guide'

Authors: NESTA and Alliance for Useful Evidence, 2016

Authors: NESTA and Alliance for Useful Evidence, 2016


Dr Nilam Ashra-McGrath, Research Uptake Manager for COMDIS-HSD shares her 5 ‘take-away’ messages from the recently published Using Research Evidence: A Practical Guide
Although this guide, published by the Alliance of Useful Evidence and NESTA, is aimed at those working to change UK policy, much of it is applicable to international development. It offers a good overview of some of the methods that are commonly used to generate research evidence, as well as touching on their pitfalls and assumptions. Among the many sensible messages are 5 good reminders:
1: Not all evidence is equal
Selective use of evidence (known as confirmation bias) via literature reviews rather than systematic reviews can skew everything from research design through to policy discussions. Literature reviews allow us to ‘cherry pick’ the evidence that best fits our argument and justification for research. The guide reminds us that bias – be it based on optimism, hindsight or loss-aversion – can lead us to engage not in ‘evidence-based policy’ but in ‘policy-based evidence’, where our conclusions have already been formed and we are retro-fitting literature and methods to support that conclusion.
Let’s not forget also that esteemed journals are prone to bias, with positive results more likely to be published, while a staggering 65% of negative studies are not even being written up. This has far-reaching consequences, and begs the question of how many policies have been implemented based on positive studies alone. Surely knowing what doesn’t work is just as important?
2: Quality matters
Peer reviewed papers are still seen as the ‘gold standard’ to assess quality, but if journals are prone to publication bias, then this clearly presents a problem; likewise with another gold standard of quality: the systematic review. As the guide points out, a systematic review is “only really as good as the quality of the studies it is based on” (p36). Judging the quality of evidence can therefore be slippery. Researchers have varying views on what quality means (though they won’t always admit this). Is it about methods, integrity, utility, or usefulness? The default position appears to be that research methods determine the quality of evidence, but here we have another ‘hierarchy of evidence’ to consider (see p32-33).
3: Rapid reviews – timing matters
It’s a long road from research to publication, and policymakers have days, if not hours, to make decisions. A robust systematic review can take 6-12 months, and a ‘rapid review’ can take 1-2 months. This means that there are clear advantages to rapid reviews, but the guide makes clear that rapid reviews should follow a systematic process, i.e. have a clear methodology so that the review can be added to when new research becomes available. Databases such as 3ie and Cochrane contain ‘off-the-shelf’ systematic reviews that will help researchers working in time sensitive contexts.
4: Context matters
The guide contains an important reminder that we are predisposed to use methods that we are comfortable with, rather than what suits the context in which the research will take place.
5: Communication matters
By this I mean sharing everything from your research methodology, through to interim and full results, and not just leaving everything until the end of your research to be shared in one academic paper. The Easy, Attractive, Social and Timely (EAST) framework, will help decision makers, and those who supply them with evidence, make more effective and efficient policy.
Aside from the additional instructions to use Google Scholar and stay off Wikipedia, this guide offers many important reminders (all evidence-based, of course). You could skim through the key messages at the end of each section, or you could invest a couple of hours reading this cover to cover. I recommend taking a couple of hours.

Bold media plan and strong lifestyle messages take ARK’s NCD work to the nation

Rumana being interviewed by TV journalist

ARK’s Dr Rumana Huque being interviewed at the national NCD workshop by a TV journalist


A bold media strategy targeting top TV and print journalists has allowed our ARK Foundation partners to reach millions with their message about better prevention and treatment of non-communicable diseases (NCDs) in Bangladesh.
Strong lifestyle messages about unhealthy food habits, low levels of physical activity, smoking and pollution were at the centre of ARK’s recent national workshop on NCDs and helped secure prominent TV coverage for the event across Bangladesh’s three main news channels, as well as wide coverage in the top-rated newspapers and their online versions.
The event, however, went beyond public health headlines and started a national dialogue on the practical service delivery steps that will help Bangladesh reduce the personal, social and economic impact of NCDs. Currently, NCDs, such as cardiovascular disease and diabetes, are responsible for more than 60% of Bangladesh’s annual mortality and account for 60% of the country’s disease burden (measured by financial cost and years of quality life lost).
The event was co-hosted by ARK and the Non-Communicable Disease Control (NCDC) Unit of the Directorate General of Health Services (DGHS). More than 60 participants from all levels of the health service, including delegates from the World Health Organization, came together to share ideas on how to improve prevention, diagnosis and treatment of NCDs in primary care.
According to Dr Rumana Huque, Executive Director of ARK, a key factor in the success of the event was the decision to include managers from every level of the health service.
‘The participants were diverse and that was very important. We had local level healthcare managers who have the practical knowledge of what is happening on the ground to control and treat NCDs. But we also had mid-level programme managers who support them and the senior-level policymakers who take the final decisions.
‘So what came out at the workshop were the challenges that service providers are already facing and the recommendations that we have generated through or work at ARK.
‘Through our research we know that we need more counselling for NCD patients, better training for doctors and health providers, a better supply of medications, improved record keeping and stronger referral links between different parts of the health service.’
Dr Huque, who is part of the core team drafting the Sector Programme – the strategic investment programme for the next five years – added that workshop had been very timely.
‘The workshop helped everyone focus on the priorities; specifically improved NCD services and better lifestyle education. Senior managers and policy makers took note and said that they would be feeding what they had learned into the next Sector Programme.’
Giving the keynote speech at the workshop, Professor Dr Abul Kalam Azad, DGHS Additional Director General (Planning and Development), told delegates that NCDs are responsible for 62% of deaths happening every year in Bangladesh.

Key speakers at ARK’s national NCD workshop. From left: Dr Rumana Huque, Executive Director of ARK, Prof Dr Abul Kalam Azad, DGHS Additional Director General (Planning and Development), Prof Dr Enayet Hussain, NCDC Unit Line Director


He said that Bangladesh had not placed sufficient importance on NCDs, with catastrophic results in terms of premature mortality.
As part the COMDIS-HSD programme, ARK has been working with primary health care facilities in Bangladesh to establish better screening, treatment and referral processes for people with NCDs. Their experience and research findings were fed into group discussions to identify urgent actions that will help Bangladesh achieve its Sustainable Development Goal target of reducing NCD premature mortality by one third by 2030. These include the more timely supply of medicines, a wider range of medicines and dedicated doctors and health educators in ‘NCD corners’ in district hospitals.
Find out more:

What did we achieve in 2015? See our year in pictures

A happy father and son after seasonal malaria chemoprevention treatment in Ghana

A happy father and son after seasonal malaria chemoprevention treatment in Ghana


HERD won a WHO ‘No Tobacco’ award; we took the stage at world conferences on lung and urban health; we ran our first journal paper writing workshop; and ARK made the news on national TV channels across Bangladesh for their work on non-communicable diseases. It has been a year of major achievement for COMDIS-HSD partners and we’re celebrating and sharing these in our 2015 Review.
Click here to see more of our year in pictures.
 

Lift off for our writing workshop: partners aim for paper in 6 days

rocket-pencilCOMDIS-HSD partners have come together for an intensive writing workshop aimed at transforming some of our latest research into high-quality draft papers ready for submission and review.

The 6-day workshop, which is taking place in Amsterdam, will guide partners through each stage of writing their research paper.

This will range from developing the introduction, methods, results and discussion sections, through to handling tables, figures, references, online electronic submission, peer review and revision.

In this hands-on week of writing, participants will be individually mentored by experienced researchers from the International Union Against Tuberculosis and Lung Disease (The Union) and Medecins Sans Frontieres (MSF). The Union and MSF work with the World Health Organization to offer this and other courses under the collective title of SORT-IT (structured operational research training initiative).

According to Professor Anthony Harries, lead facilitator of the workshop and Senior Advisor and Director of the Department of Research at The Union, the module is about developing confidence as well as practical skills:

‘Many researchers do a lot of work in the field developing a study protocol, collecting and analysing data, but get blocked when it comes to writing up the results.

‘This week should remove some of the myths surrounding scientific writing. Writing is like any skill, it can be learned and it is much more satisfying and productive when you know how.’

Partners will be working with research data from some of their latest COMDIS-HSD studies, including research that focuses on understanding current antibiotic use among children in China, the media’s response to urban health issues in Nepal and delivering enhanced cardiovascular disease care through rural health facilities in Pakistan.

We will be tweeting throughout the week with progress and top tips. Follow us on @COMDISResearch and use the hashtag #COMDISwrites to get involved.

See all our published research papers here.

Sleeves up for Swazi partners on Global Handwashing Day

Student nurse Lindokuhle Mhlongo demonstrates good handwashing technique to a patient

Student nurse Lindokuhle Mhlongo demonstrates good handwashing technique to a patient


COMDIS-HSD partners, Good Shepherd Hospital in Swaziland, rolled up their sleeves on Global Handwashing Day to spread the word about good hand hygiene. A team of 10 student nurses, together with staff from the hospital’s Infection Prevention and Control (IPC) team, demonstrated good handwashing practice to patients as they waited in the outpatients’ area.
Patients were also shown a video and given a leaflet explaining the importance of handwashing and encouraging them to use soap, wash often and wash long enough. Handwashing is the most effective and simplest thing you can do to prevent infections, including hospital acquired infections.
Patients were able to ask their own questions, such as whether running water is necessary as opposed to just using a bucket and dipping their hands in.
The event, which was fun as well as informative, coincides with wider work to establish a new IPC committee to provide stronger guidance on IPC adherence and improvements throughout the hospital. These will include developing the hospital’s infrastructure to ensure better access to hand hygiene facilities and ongoing improvements to sanitary facilities and ventilation.
COMDIS-HSD is also helping the hospital secure the necessary resources to ensure hand gel is available on every ward.
Read more about our IPC work here.

World No Tobacco award for Nepal partners HERD

HERD executive director Dr Sushil Baral (left) accepts the award from Dr Frank Paulin, acitng WHO representative, Nepal

HERD executive director Dr Sushil Baral (left) accepts the No Tobacco award from Dr Frank Paulin, acting WHO representative, Nepal


Health Research and Social Development Forum (HERD) has been presented with a World No Tobacco Award 2015 by the World Health Organization (WHO).
The award recognises HERD’s work to develop and implement a behaviour change intervention for tobacco cessation – a project that has already resulted in a 37% quit rate among smokers.
Supported by COMDIS-HSD, HERD has focused specifically on the provision of individual counselling, education and follow-up sessions for lung health patients visiting primary health care centres.
Receiving the award on behalf of his team, HERD executive director, Dr Sushil Baral, said: “We have been working very closely with the Ministry of Health and Population in the sector of tobacco control since our establishment in 2004. We started with the inter-linkage of tobacco users being vulnerable to tuberculosis.
“Our approach has been generating the evidence, informing the policy and changing the practice. We are proud that our effort, through the feasibility study intervention in the primary health care settings, has been acknowledged by the ministry and WHO.”
HERD project co-ordinator for tobacco control, Sudeepa Khanal, added: “It is a great moment for us as all the effort we have put in to tobacco control initiatives has finally paid off.”
Shraddha Manandhar, research officer, who observed and monitored the intervention in one of the primary health centres in Kathmandu, explained: “We had to conduct several meetings and follow-up sessions to finally come up with a successful result – a 37% quit rate among smokers who received the intervention support. The wait has been worthwhile.”
Every year, WHO gives the World No Tobacco Day awards to individuals and institutions selected for their long-term commitment and outstanding contribution to research, advocacy, health promotion, capacity building and other activities that promote and enforce tobacco control.
Read more about how the team developed the intervention in the HERD LinkedIn blog.